Generalized Pustular Psoriasis (GPP) News & ResearchComorbidity Burden Higher in Generalized Pustular PsoriasisMost prevalent conditions in GPP were hypertension, psoriatic arthritis, type 2 diabetes, hyperlipidemiaBy Physician’s Briefing Staff | October 19, 2022FDA Approves SPEVIGO for Generalized Pustular Psoriasis FlaresThe monoclonal antibody infusion is approved for use in adultsBy Physician’s Briefing Staff | September 06, 2022Treatment Needs Often Unmet for Generalized Pustular PsoriasisPatients with flares more likely to have inpatient, emergency department visitsBy Physician’s Briefing Staff | August 15, 2022